NT-05 PATIENT ACCEPTANCE OF ROUTINE RESAMPLING OF GLIOBLASTOMA: A QUALITATIVE STUDY

INTRODUCTION: The routine resampling of glioblastoma may be very useful to guide patient care after initial surgery, radiation, and chemotherapy, akin to bone marrow biopsy in leukemia patients. Qualitative research methodology was used to explore the views of patients on this issue. Qualitative res...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro-oncology (Charlottesville, Va.) Va.), 2014-11, Vol.16 (suppl 5), p.v160-v160
Hauptverfasser: Bernstein, M., Dirks, P., Mason, W., Mir, T.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:INTRODUCTION: The routine resampling of glioblastoma may be very useful to guide patient care after initial surgery, radiation, and chemotherapy, akin to bone marrow biopsy in leukemia patients. Qualitative research methodology was used to explore the views of patients on this issue. Qualitative research is a form of social sciences investigation, focusing on the experiences of participants in real, not experiment settings. It has not been used much by clinicians, especially neuro-oncologists, but this is slowly changing. METHODS: 30 patients with glioblastoma were recruited from a neuro-oncology clinic in a cancer center serving three adult teaching hospitals. The protocol was passed by the IRB. The study subjects were given semi-structured interviews using an interview guide, and the recorded data assessed using modified thematic analysis and grounded theory. Overarching themes were extracted from the data. RESULTS: Several themes arose - the primary and most important was that routine resampling of glioblastoma was acceptable to most patients. CONCLUSIONS: Using qualitative research methodology, we can learn insights about patients' experience that we cannot learn from quantitative research. This information can help us learn: 1) what our patients are feeling; 2) how we can better talk to them; 3) what issues are important to them to talk about; 4) how we can improve their care and their perception of care; and 5) how we can better conduct clinical research. This can lead to improvement in the quality of our neuro-oncology patients' experience and help facilitate the practice of patient-centered care for brain tumor patients. This particular study demonstrates that routine resampling of glioblastoma is acceptable to patients, and more generically, it represents a novel way of assessing if innovative treatments would be acceptable to the patients they are designed for by directly asking patients for their views.
ISSN:1522-8517
1523-5866
DOI:10.1093/neuonc/nou265.5